RDY Net Income From Continuing Ops from 2010 to 2025

RDY Stock  USD 13.60  0.39  2.79%   
Dr Reddys Net Income From Continuing Ops yearly trend continues to be fairly stable with very little volatility. Net Income From Continuing Ops is likely to outpace its year average in 2025. During the period from 2010 to 2025, Dr Reddys Net Income From Continuing Ops regression line of annual values had r-squared of  0.51 and arithmetic mean of  26,308,439,467. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2001-03-31
Previous Quarter
13.4 B
Current Value
14 B
Quarterly Volatility
5.7 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

RDY Net Income From Continuing Ops Regression Statistics

Arithmetic Mean26,308,439,467
Geometric Mean0.00
Coefficient Of Variation78.68
Mean Deviation15,849,784,016
Median21,512,000,000
Standard Deviation20,700,323,001
Sample Variance428503372.4T
Range67.2B
R-Value0.72
Mean Square Error223339897.2T
R-Squared0.51
Significance0
Slope3,115,800,352
Total Sum of Squares6427550585.3T

RDY Net Income From Continuing Ops History

202567.2 B
202464 B
202355.7 B
202245.1 B
202123.6 B
202019.1 B
201919.5 B

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income From Continuing Ops64 B67.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.